Skip to content

SISTIM: Subacromial Impingement Syndrome: The Identification of etiologic Mechanisms will have a new acronym respectively, SuSy SuSy: Subacromial Impingement Syndrome: The Identification of etiologic Mechanisms

SISTIM: Subacromial Impingement Syndrome: The Identification of etiologic Mechanisms will have a new acronym respectively, SuSy SuSy: Subacromial Impingement Syndrome: The Identification of etiologic Mechanisms - SISTIM, new acronym, SuSy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41430
Enrollment
110
Registered
2010-02-25
Start date
2010-04-28
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painful arc syndrome subacromial pain syndrome

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The clinical diagnosis of stage I or II SIS is made when one or more of the following mentioned factors exist, next to a positive Neer impingement test and a positive Hawkins test.;Patients* history: - Diffuse unilateral shoulder pain for > 3 months; - Pain during activities with abduction, retroflexion and/or internal rotation (i.e. closing the door, putting on jacket, overhead activities); - Pain at night or incapable of lying on the shoulder.;Physical examination: - Diffuse pain at palpation of the greater tuberosity; - Disturbed scapulohumeral rhythm; - Painful arc; - No complaints or sings of pathologies on the contralateral shoulder; - > 90 Degrees external rotation in 90 degrees of passive abduction (frozen shoulder); - Positive Yocum test.

Exclusion criteria

Exclusion criteria: Patients are excluded if one of the following characteristics is found: - 60 years old - Restrictions in passive movements of glenohumeral joint/frozen shoulder; - History of fracture or dislocation of the shoulder; - History of surgery around the shoulder (in anamnesis); - Tumors; - No informed consent; - Clinical and radiographic signs of comorbidities or alternative diagnoses on the affected shoulder (glenohumeral instability, glenohumeral movement restriction, glenohumeral osteoarthritis or arthritis, rheumatic disorder, labrum lesions, a history of trauma on the affected shoulder, biceps muscle tendinitis, complete (full thickness) rotator cuff rupture, cervical radiculopathy, PASTA lesion, or calcifying tendinitis); - Contralateral shoulder with clinical signs of shoulder complaints. - Pacemaker or other electronic implants

Design outcomes

Primary

MeasureTime frame
Primary study parameters: - Cranial translation of the humerus as measured on AP-radiographs in rest, and with a constant abduction and adduction force exertion against an force transducer - Scapulohumeral rhythm and shoulder-arm Range of Motion as measured with an electromagnetic motion tracking device.

Secondary

MeasureTime frame
All study parameters categorized for etiological subgroups: 1) Relative cranial translation of the humerus: 3D arm-scapula motion registration (3D RoM), muscle activation parameters of shoulder and rotator cuff muscles (EMG), static acromiohumeral distance (sAH) on AP-radiographs *at rest* and with exerted ab- and adduction moments (dAH), integrate bony 3D-shape with 3D RoM to describe dynamic AH (3DdAH). 2) Structural (bony) narrowing of the subacromial space: shape parameters of scapula (i.e. Bigliani acromion classification) and humerus, 3D kinematic analysis of scapulo-humeral motion by integration of bony 3D-shapes with 3D RoM. 3) Subacromial inflammatory processes and damaged tissues: MRI for rotator cuff and muscle quality (Goutallier score) and signs of bursitis, tendinitis and rotator cuff ruptures. 4) Other primary pathologies leading to SIS complaints: evaluation of MRI and radiographs for acromioclavicular-osteoarthritis, full thickness rotator cuff-ruptures, coracoid impingement and other subacromial pathologies.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)